Antitumor effects of analogs of LH-RH and somatostatin: Experimental and clinical studies
- 20 December 1990
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6), 1061-1067
- https://doi.org/10.1016/0960-0760(90)90466-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivoInternational Journal of Peptide and Protein Research, 1990
- Grwoth Inhibition of Mouse MXT Mammary Tumor by the Luteinizing Hormone-Releasing Hormone Antagonist SB-75JNCI Journal of the National Cancer Institute, 1990
- Evaluation of Receptors for Somatostatin in Various Tumors Using Different Analogs*Journal of Clinical Endocrinology & Metabolism, 1990
- Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatinBreast Cancer Research and Treatment, 1989
- Membrane Receptors for Peptides in Experimental and Human Pancreatic CancersPancreas, 1989
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancerJournal of Clinical Laboratory Analysis, 1989
- Receptors for luteinizing hormone‐releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasiaThe Prostate, 1989
- New antagonists of LHRH II. Inhibition and potentiation of LHRH by closely related analoguesInternational Journal of Peptide and Protein Research, 1988
- Carcinoma of the exocrine pancreas: A sex hormone responsive tumour?British Journal of Surgery, 1987